Search · The Cardiovascular

TheCardiovascular

Log in Become a member

60+ träffar

KVÅKVÅ

3E0D705 — Introduction of Other Antineoplastic into Mouth and Pharynx, Via Natural or Artificial Opening

KVÅKVÅ

3E0D305 — Introduction of Other Antineoplastic into Mouth and Pharynx, Percutaneous Approach

KVÅKVÅ

3E0DX05 — Introduction of Other Antineoplastic into Mouth and Pharynx, External Approach

KVÅKVÅ

3E00X05 — Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach

KVÅKVÅ

3E01305 — Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach

KVÅKVÅ

3E02305 — Introduction of Other Antineoplastic into Muscle, Percutaneous Approach

KVÅKVÅ

3E03005 — Introduction of Other Antineoplastic into Peripheral Vein, Open Approach

KVÅKVÅ

3E03305 — Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach

KVÅKVÅ

3E04005 — Introduction of Other Antineoplastic into Central Vein, Open Approach

KVÅKVÅ

3E04305 — Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach

KVÅKVÅ

3E05005 — Introduction of Other Antineoplastic into Peripheral Artery, Open Approach

KVÅKVÅ

3E05305 — Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach

KVÅKVÅ

3E06005 — Introduction of Other Antineoplastic into Central Artery, Open Approach

KVÅKVÅ

3E06305 — Introduction of Other Antineoplastic into Central Artery, Percutaneous Approach

KVÅKVÅ

3E09305 — Introduction of Other Antineoplastic into Nose, Percutaneous Approach

KVÅKVÅ

3E09705 — Introduction of Other Antineoplastic into Nose, Via Natural or Artificial Opening

KVÅKVÅ

3E09X05 — Introduction of Other Antineoplastic into Nose, External Approach

KVÅKVÅ

3E0A305 — Introduction of Other Antineoplastic into Bone Marrow, Percutaneous Approach

KVÅKVÅ

3E0B305 — Introduction of Other Antineoplastic into Ear, Percutaneous Approach

KVÅKVÅ

3E0B705 — Introduction of Other Antineoplastic into Ear, Via Natural or Artificial Opening

KVÅKVÅ

3E0BX05 — Introduction of Other Antineoplastic into Ear, External Approach

KVÅKVÅ

3E0C305 — Introduction of Other Antineoplastic into Eye, Percutaneous Approach

KVÅKVÅ

3E0C705 — Introduction of Other Antineoplastic into Eye, Via Natural or Artificial Opening

KVÅKVÅ

3E0CX05 — Introduction of Other Antineoplastic into Eye, External Approach

KVÅKVÅ

3E0E305 — Introduction of Other Antineoplastic into Products of Conception, Percutaneous Approach

KVÅKVÅ

3E0E705 — Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening

KVÅKVÅ

3E0E805 — Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0F305 — Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach

KVÅKVÅ

3E0F705 — Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening

KVÅKVÅ

3E0F805 — Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0G305 — Introduction of Other Antineoplastic into Upper GI, Percutaneous Approach

KVÅKVÅ

3E0G705 — Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening

KVÅKVÅ

3E0G805 — Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0H305 — Introduction of Other Antineoplastic into Lower GI, Percutaneous Approach

KVÅKVÅ

3E0H705 — Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening

KVÅKVÅ

3E0H805 — Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0J305 — Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach

KVÅKVÅ

3E0J705 — Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

KVÅKVÅ

3E0J805 — Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0K305 — Introduction of Other Antineoplastic into Genitourinary Tract, Percutaneous Approach

KVÅKVÅ

3E0K705 — Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening

KVÅKVÅ

3E0K805 — Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0L305 — Introduction of Other Antineoplastic into Pleural Cavity, Percutaneous Approach

KVÅKVÅ

3E0L705 — Introduction of Other Antineoplastic into Pleural Cavity, Via Natural or Artificial Opening

KVÅKVÅ

3E0M305 — Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach

KVÅKVÅ

3E0M705 — Introduction of Other Antineoplastic into Peritoneal Cavity, Via Natural or Artificial Opening

KVÅKVÅ

3E0N305 — Introduction of Other Antineoplastic into Male Reproductive, Percutaneous Approach

KVÅKVÅ

3E0N705 — Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening

KVÅKVÅ

3E0N805 — Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0P305 — Introduction of Other Antineoplastic into Female Reproductive, Percutaneous Approach

KVÅKVÅ

3E0P705 — Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening

KVÅKVÅ

3E0P805 — Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening Endoscopic

KVÅKVÅ

3E0Q005 — Introduction of Other Antineoplastic into Cranial Cavity and Brain, Open Approach

KVÅKVÅ

3E0Q305 — Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach

KVÅKVÅ

3E0Q705 — Introduction of Other Antineoplastic into Cranial Cavity and Brain, Via Natural or Artificial Opening

KVÅKVÅ

3E0R305 — Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach

KVÅKVÅ

3E0S305 — Introduction of Other Antineoplastic into Epidural Space, Percutaneous Approach

KVÅKVÅ

3E0U305 — Introduction of Other Antineoplastic into Joints, Percutaneous Approach

KVÅKVÅ

3E0V305 — Introduction of Other Antineoplastic into Bones, Percutaneous Approach

KVÅKVÅ

3E0W305 — Introduction of Other Antineoplastic into Lymphatics, Percutaneous Approach